Logotype for CompuGroup Medical SE & Co. KGaA

CompuGroup Medical (COP) Investor Update summary

Event summary combining transcript, slides, and related documents.

Logotype for CompuGroup Medical SE & Co. KGaA

Investor Update summary

8 Jul, 2026

Transaction overview

  • CVC Capital Partners will launch a voluntary public tender offer for all outstanding shares at €22.00 per share in cash, representing a 51.1% premium over the three-month average share price as of December 6, 2024.

  • The offer is subject to a minimum acceptance threshold of 17% and regulatory approvals, including antitrust clearance, with closing expected in the first half of 2025.

  • Upon completion, the company intends to delist, with the founding family and related shareholders retaining a 50.1% majority stake, ensuring continued family ownership.

  • No domination or profit and loss transfer agreement will be entered into for two years post-closing.

  • The management and supervisory boards intend to recommend acceptance of the offer, subject to review of the offer documentation.

Strategic rationale and partnership details

  • The partnership aims to accelerate innovation and growth, leveraging CVC's healthcare and software expertise and global network.

  • Strategic priorities include operational excellence, product synchronization, and development of digital co-pilot functions for healthcare professionals.

  • The collaboration targets investments in modern, data-driven products and enhanced service quality for healthcare professionals.

  • Governance structure remains unchanged, with key leadership positions retained by the founding family.

  • All parties are committed to the existing strategy focused on innovation and growth.

Shareholder impact and offer evaluation

  • The offer price provides a significant premium to recent share prices and exceeds average broker and analyst target prices.

  • Shareholders can realize immediate cash value, while those who do not tender retain exposure to future risks and opportunities.

  • Fairness opinions from Deutsche Bank and J.P. Morgan support the offer price as fair.

  • The offer contemplates a subsequent delisting from the stock exchange.

  • Continued high investment in innovation and growth is planned under private ownership.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more